Look at the organizational chart for a home health agency. Click here to view the chart. A nursing assistant is at a patient’s home giving the patient a bath. While bathing the patient, the nursing assistant observes a rash on the patient’s back, arms, and legs. According to this organizational chart, who will the nursing assistant report the rash to?

A. the coordinating RN
B. the home health administrator
C. LPN/LVN care
D. RN care

Anurse is caring for a client who has acute heart failure and is receiving furosemide via iv bolus. the nurse should identify that which of the following findings indicates a desired therapeutic effect? a. increased sputum production b. decreased weight c. decreased blood glucose level d. increased blood pressure

Anurse recently administered filgrastim intravenously to a client who has cancer and is receiving cytotoxic chemotherapy. for which of the following data, discovered after the medication was administered, should the nurse consider filling an incident report? a. the client had chemotherapy 12 hr before the medication was administered. b. the nurse flushed the client’s iv line with d5w before and after the medication was administered. c. the client’s absolute neutrophil count was 2,500/mm^3 before the medication was administered. d. the medication vial sat at the room temperature for 2 hr before it was administered.

Cj is a 53 year old african american female presenting to pharmacy for first-time certification and cmr so that she may start getting her medications at no cost. cj states that her main concern about her health is her diabetes. pmh: t2dm, htn, hyperlipidemia sh: denies tobacco and illicit drug use, occasional alcohol use (1-2 drinks/month) fh: unknown allergies: penicillin (unknown reaction; had reaction when young). medications: lisinopril 5 mg daily aspirin 81 mg daily simvastatin 20 mg daily wt 231 lbs (105 kg), ht 5’6”, bmi 37.3 (obese), ibw 59.3 kg, bp 145/80, hr 98, random blood glucose 395, a1c 11.2%, estimated 10-year ascvd risk 9.5% drug-related problems: 1. uncontrolled t2dm 2. uncontrolled htn 3. suboptimal statin intensity 1) identify two pieces of objective data included in this case: 2) what kind of monitoring needs performed for the new prescription for this patient? 3) based on your case how would you counsel the patient on the new prescription medication? provide examples of specific aspects you would include in your patient education. 4) review your patient case. identify any medications that do not have a corresponding disease state. 5) review your patient case. identify any disease states are not treated by current medications. 6) what otc (over the counter) product would you recommend for this patient (based on the patient request for an otc product? include dose, frequency of administration, route of administration, and critical counseling points.